bioAffinity Technologies, Inc.(BIAF)

Medical - Diagnostics & Research · San Antonio, TX

$6.12-0.07 (-1.13%)

Delayed quote: Oct 6, 2026, 11:24 AM EDT

EV/EBIT Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBIT ratio is N/A as of 2026-10-06T15:26:08.777Z.

Stored calculation inputs

Calculation as of: 2026-10-06T15:26:08.777Z.

Quote observation: 2026-10-06T15:24:11.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 2,563,491
Total debt · period ending 2026-06-30: 1,435,005
Cash · period ending 2026-06-30: 2,429,719
TTM operating income · period ending 2026-06-30: -12,381,649

FMP input reference: b8a0cb47064437e8b9c77c3ec53eeb060705b9d611480c07f1c1fa4a72564033

EV/EBITDA|EV/Sales|Operating Income|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

BIAF EV/EBIT Ratio Metrics

EV/EBIT RATIO

N/A

BIAF Competitors' EV/EBIT Ratio

BIAF

bioAffinity Technologies, Inc.

Current

Market Cap

$2.56M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NUWE

Nuwellis, Inc.

vs BIAF

Market Cap

$2.56M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

FBLG

FibroBiologics, Inc. Common Stock

vs BIAF

Market Cap

$2.53M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

JAGX

Jaguar Health, Inc.

vs BIAF

Market Cap

$2.66M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ISPC

iSpecimen Inc.

vs BIAF

Market Cap

$2.67M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MBRX

Moleculin Biotech, Inc.

vs BIAF

Market Cap

$2.45M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CELZ

Creative Medical Technology Holdings, Inc.

vs BIAF

Market Cap

$2.33M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ONCO

Onconetix, Inc.

vs BIAF

Market Cap

$2.31M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GOVX

GeoVax Labs, Inc.

vs BIAF

Market Cap

$2.23M

EV/EBIT Ratio

N/A

TTM Avg

26760113783.26x

3Y Avg

32032508565.60x

5Y Avg

32032508565.60x

ADGM

Adagio Medical Holdings, Inc.

vs BIAF

Market Cap

$2.96M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/EBIT RATIO	TTM	3Y	5Y
bioAffinity Technologies, Inc. (BIAF)	$2.56M	N/A	N/A	N/A	N/A
Nuwellis, Inc. (NUWE)vs ›	$2.56M	N/A	N/A	N/A	N/A
FibroBiologics, Inc. Common Stock (FBLG)vs ›	$2.53M	N/A	N/A	N/A	N/A
Jaguar Health, Inc. (JAGX)vs ›	$2.66M	N/A	N/A	N/A	N/A
iSpecimen Inc. (ISPC)vs ›	$2.67M	N/A	N/A	N/A	N/A
Moleculin Biotech, Inc. (MBRX)vs ›	$2.45M	N/A	N/A	N/A	N/A
Creative Medical Technology Holdings, Inc. (CELZ)vs ›	$2.33M	N/A	N/A	N/A	N/A
Onconetix, Inc. (ONCO)vs ›	$2.31M	N/A	N/A	N/A	N/A
GeoVax Labs, Inc. (GOVX)vs ›	$2.23M	N/A	26760113783.26x	32032508565.60x	32032508565.60x
Adagio Medical Holdings, Inc. (ADGM)vs ›	$2.96M	N/A	N/A	N/A	N/A

EV/EBIT Ratio Formula & Definition

EV/EBIT = Enterprise Value / EBIT (TTM)

Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EV/EBIT Ratio: N/A

BIAF EV/EBIT Ratio Metrics

BIAF Competitors' EV/EBIT Ratio

EV/EBIT Ratio Formula & Definition

Related Metrics